Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa - Institut Pasteur Access content directly
Journal Articles Journal of Hepatology Year : 2018

Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa

Gibril Ndow
  • Function : Author
  • PersonId : 1014238
Amie Ceesay
  • Function : Author
Adam Jeng
  • Function : Author
Harr Freeya Njai
  • Function : Author
Umberto d'Alessandro
  • Function : Author
Maud Lemoine
  • Function : Correspondent author
  • PersonId : 982266

Connectez-vous pour contacter l'auteur

Abstract

To eliminate hepatitis B virus (HBV) infection, it is essential to scale up antiviral treatment through decentralized services. However, access to the conventional tools to assess treatment eligibility (liver biopsy/Fibroscan®/HBV DNA) is limited and not affordable in resource-limited countries. We developed and validated a simple score to easily identify patients in need of HBV treatment in Africa.
Fichier principal
Vignette du fichier
1-s2.0-S0168827818321020-main.pdf (739.85 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-01896895 , version 1 (16-10-2018)

Licence

Attribution - NonCommercial - NoDerivatives

Identifiers

Cite

Yusuke Shimakawa, Ramou Njie, Gibril Ndow, Muriel Vray, Papa Saliou Mbaye, et al.. Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa. Journal of Hepatology, 2018, 69 (4), pp.776 - 784. ⟨10.1016/j.jhep.2018.05.024⟩. ⟨pasteur-01896895⟩
337 View
217 Download

Altmetric

Share

Gmail Facebook X LinkedIn More